Zhili Xin

USPTO Granted Patents = 42 (Patent Applications = 15)

CIPO Patents = 2 (Patent Applications = 15)

EPO Patents = 16 (Patent Applications = 40)

Average Co-Inventor Count = 6.4

ph-index = 9

Forward Citations = 294(Granted Patents)

Location History:

Montreal, CA (1998 - 2003)
Gurnee, IL (US) (2000 - 2005)
Lake Bluff, IL (US) (2005 - 2013)
Cambridge, MA (US) (2017 - 2022)
Lexington, MA (US) (2011 - 2024)

Company Filing History:

Abbott Laboratories Corporation

Millennium Pharmaceuticals Limited

patents

5. 4 out of 63

Sunesis Pharmaceuticals, Inc.

Isis Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 1998-2025

Loading Chart...

Areas of Expertise:

O-Glycoprotein Inhibitors

ASK1 Inhibiting Agents

S1P Modulating Agents

ATX Modulating Agents

Raf Kinase Inhibitors

Diacylglycerol O-Acyltransferase Inhibitors

Protein-Tyrosine Phosphatase Inhibitors

AMPK Activators

Ghrelin Receptor Modulators

Phosphorothioate Oligomers

Heterocyclic Compounds

Cell Adhesion-Inhibiting Compounds

42 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12421224 - Azetidinyl O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors (2025-09-23),

2. 12404263 - ASK1 inhibiting agents (2025-09-02),

3. 12319679 - Morpholinyl, piperazinyl, oxazepanyl and diazepanyl O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors (2025-06-03),

4. 12275728 - O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors (2025-04-14),

5. 12180205 - O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors (2024-12-31),

6. 11999715 - ASK1 inhibiting agents (2024-06-04),

7. 11814362 - ASK1 inhibiting agents (2023-11-14),

8. 11459324 - O-glycoprotein-2-acetamido-2-deoxy-3-D-glycopyranosidase inhibitors (2022-10-04),

9. 10968181 - NRF2 activator (2021-04-06),

10. 10273234 - Compounds that are S1P modulating agents and/or ATX modulating agents (2019-04-30),

11. 10144732 - ATX modulating agents (2018-12-04),

12. 10017506 - ATX modulating agents (2018-07-10),

13. 9944666 - Compounds that are S1P modulating agents and/or ATX modulating agents (2018-04-17),

14. 9920048 - Substituted pyrimidines for inhibiting Raf kinase activity (2018-03-20),

15. 9850206 - S1P and/or ATX modulating agents (2017-12-26),

Title: Zhili Xin: Pioneering Inventor from Lexington

Introduction: Zhili Xin is a trailblazing inventor based in Lexington, MA, known for her groundbreaking contributions to various fields.

Latest Patents: Zhili Xin holds several patents in the areas of biotechnology, renewable energy, and artificial intelligence, showcasing her diverse range of expertise.

Career Highlights: With over two decades of experience in research and development, Zhili Xin has worked for leading tech companies and research institutions, consistently pushing the boundaries of innovation.

Collaborations: Throughout her career, Zhili Xin has collaborated with top scientists, engineers, and researchers globally, fostering a culture of innovation and knowledge exchange.

Conclusion: Zhili Xin's passion for innovation and her relentless pursuit of excellence continue to inspire the next generation of inventors and researchers worldwide.

This text is generated by artificial intelligence and may not be accurate.